皮肤淋巴瘤的放射治疗:来自EORTC皮肤淋巴瘤瘤组的建议
Khaled Elsayad1, Emmanuella Guenova2, Chalid Assaf3
1Radiation Oncology, University Hospital of Münster, Münster, Germany; Department of Radiation Oncology, UKGM Marburg, Marburg, Germany; Marburg Ion-Beam Therapy Center (MIT), Department of Radiation Oncology, UKGM Marburg, Marburg, Germany; University Cancer Center (UCT) Frankfurt-Marburg, Marburg, Frankfurt, Germany.
皮肤淋巴瘤的低剂量放射治疗正在增加,但需要更多的证据. 这份专家意见审查了文献,以推原发性皮肤淋巴瘤的辐射剂量,强调了临床试验的必要性.
科学领域:
- 皮肤病学 皮肤病学
- 辐射瘤学 辐射瘤学
- 在瘤学瘤学.
背景情况:
- 对于原发性皮肤淋巴瘤 (PCL) 的低剂量放射治疗的使用正在增加.
- 缺乏可控临床试验,以确定特定PCL类型的标准辐射剂量.
- 放射性瘤学家目前因临床证据不足而做出个性化治疗决定.
研究的目的:
- 为优化PCL辐射瘤实践提供专家建议.
- 审查现有文献,并为所有PCL亚型制定基于证据的指南.
- 强调迫切需要进行前性试验以指导辐射剂量.
主要方法:
- 专家意见综合. 专家意见综合.
- 关于原发性皮肤淋巴瘤和放射治疗的综合文献综述.
- 开发基于证据的建议.
主要成果:
- 目前的文献审查为专家关于PCL辐射剂量的建议提供了基础.
- 识别需要进一步研究的知识差距.
- 需要进行前性试验,以确定影响不同辐射剂量的结果的因素.
结论:
- 建议提出专家建议,以加强目前针对PCL的放射瘤学实践.
- 进一步的临床研究,特别是前性试验,对于制定最终的放射治疗指南至关重要.
- 在PCL中优化辐射剂量需要更强的证据基础来改善患者的治疗结果.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
08:54Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
相关概念视频
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
